Aviso Financial Inc. Cuts Stock Holdings in CVS Health Corporation $CVS

Aviso Financial Inc. lowered its stake in CVS Health Corporation (NYSE:CVS) by 52.2% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,690 shares of the pharmacy operator’s stock after selling 8,383 shares during the quarter. Aviso Financial Inc.’s holdings in CVS Health were worth $580,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Harbor Capital Advisors Inc. lifted its position in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares in the last quarter. Corundum Trust Company INC bought a new stake in CVS Health in the 3rd quarter worth approximately $29,000. Front Row Advisors LLC raised its holdings in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares in the last quarter. Twin Peaks Wealth Advisors LLC bought a new position in shares of CVS Health during the 2nd quarter valued at approximately $36,000. Finally, SOA Wealth Advisors LLC. grew its holdings in shares of CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on CVS. Piper Sandler reiterated an “overweight” rating and set a $101.00 price objective (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Mizuho increased their price target on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Sanford C. Bernstein reissued a “market perform” rating and set a $91.00 price objective on shares of CVS Health in a research note on Tuesday, January 6th. Truist Financial set a $100.00 price objective on CVS Health in a research note on Wednesday, December 10th. Finally, Robert W. Baird boosted their target price on CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research report on Wednesday, December 10th. Nineteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $94.91.

CVS Health Trading Up 2.2%

CVS opened at $79.74 on Monday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The stock’s 50 day moving average price is $78.39 and its 200-day moving average price is $77.29. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15. The stock has a market cap of $101.44 billion, a price-to-earnings ratio of 57.78, a P/E/G ratio of 0.83 and a beta of 0.49.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same quarter in the previous year, the business earned $1.19 EPS. CVS Health’s revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is currently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.